Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.2 to v3.8.0 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-31T13:12:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology across NIH content.
    Difference
    1%
    Check dated 2026-10-24T13:41:41.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer's site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T13:42:17.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T13:45:40.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The study record page continues to display a 403 Forbidden error instead of study information.
    Difference
    0.2%
    Check dated 2026-10-03T14:13:07.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The study details page now displays a 403 Forbidden message, replacing the previous content and preventing access to the study record.
    Difference
    0.5%
    Check dated 2026-09-26T16:34:02.000Z thumbnail image

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.